年間情報：医薬品のブラジル・ロシア・インド・中国市場

Abstract

Evaluate the status, opportunities and threats for pharmaceutical companies in Brazil, Russia, India and China now and in the future. Market forecasts to 2013 are provided, plus free quarterly-updated market outlook reports on each country, keeping you up to date with developments for a full year.

Many are concerned that a potential global economic downturn could blunt the rapid growth in the BRIC countries. Is this a time of exciting opportunity or commercial danger for pharmaceutical manufacturers? This report separates the fact from the fiction and is essential in making sound, impartial business judgements.

This insightful report provides:

5-year forecasts to 2013 and market valuations for each market
A detailed analysis of the health structure, funding, service and outlook
Quarterly updated reports of key developments in the market

These leading emerging and rapidly-growing economies represented a total market of 2.76 billion people and a combined GDP of US$6.1 trillion in 2007. But where do commercial opportunities exist for pharmaceutical companies now, and what are the future prospects?

Putting things in perspective

The BRIC countries' pharmaceutical markets are currently valued at US$54.9 billion. This is a large sum of money, but is collectively lower than found in leading markets such as the USA and Japan. Growth rates, ranging from 5% in Brazil to 15% in Russia are impressive, but the low starting point - along with a range of other operational issues - means companies must be targeted in the opportunities they pursue.

Opportunities do exist

There are, of course, wide regional differences in expenditure levels within the BRIC countries, far more so than in developed countries where health systems have evolved to provide a more uniform level of coverage. All four countries have a relatively wealthy urban population with a far greater spending power than their respective national average. In the case of China and India, these urban populations have grown rapidly, and number hundreds of millions. The challenge for these countries is to extend this level of wealth to the rest of the population, in order that better levels of healthcare become affordable.

A long haul

This is evolution not revolution, and change will be incremental. Short-term opportunities exist in meeting the health demands of the burgeoning middle classes, and future prospects are bright, where steady growth in BRIC markets will erode commercial differences with the established markets in North America, Japan and Europe.

Current and accurate decision support information is vital

Effective planning is vital and that is why Espicom, the leading provider of pharmaceutical market intelligence, has issued this report collection The Market for Pharmaceuticals in Brazil, Russia, India & China 2008. For each country there is a comprehensive examination of the market for pharmaceuticals which covers all aspects of the operating environment from the regulatory situation through health provision/expenditure to domestic production. Importantly, each market evaluation includes 5-year growth forecasts and SWOT analysis. An additional benefit - at no extra cost - is that concise quarterly-updated outlook reports are included in the price.

Brazil Pharmaceutical Market Intelligence Report

EXECUTIVE SUMMARY
PHARMACEUTICAL MARKET
Current Size
Projections
Market Structure
- Pharmacy Sector
- Public Sector
- OTC Medicines
- Generic Medicines
- Domestic Production
  - Trade Associations
- Imports
- Exports
- Research & Development
Market Developments
- More competition in the OTC sector
- Serious problems for pharmacy chain
- Clinical development of dengue vaccine
- Fighting HIV/AIDS
- Novartis' manufacturing expansion plans
- Zydus Cadila' s acquisition of Brazil' s Nikkho
- EMS' manufacturing expansion plans
- Programme to subsidise contraception
- Novo Nordisk' s manufacturing expansion plans
- New drug price readjustments
KEY NATIONAL DATA PROJECTIONS
Methodology and Sources

List of Tables

Summary of the Brazilian Pharmaceutical Market, 2007
SWOT Analysis of the Brazilian Pharmaceutical Market, 2007
Espicom Analysis of the Brazilian Healthcare Sector, 2007
Pharmaceutical Market, 1997-2006
Pharmaceutical Market by Value per Month, 1999-2006 (R$ 000)
Pharmaceutical Market by Value per Month, 1999-2006 (US$ 000)
Pharmaceutical Market by Volume per Month, 1999-2006 (000 Units)
Pharmacy Sector by Value, 2003-2006
Outlook for the OTC Industry, 2005-2006
Generics Pharmacy Sales by Value and Volume, 2000-2006
Gross Production, 1996-2004
Gross Production by Leading State, 1997-2004 (R$ Million)
Workforce, 1997-2004
Summary of Pharmaceutical Imports, 2001-2005 (US$ Million)
Raw Materials & Medicaments as Percentage of Pharmaceutical Imports, 2001-2005
Change in Pharmaceutical Imports, 2000-2004 (%)
Leading Suppliers by Country/Region, 2005 (US$000)
Leading Suppliers of Raw Materials, 2005 (US$000)
Leading Suppliers of Medicaments, 2005 (US$000)
Imports of Pharmaceuticals, 2001-2005 (US$000s)
Pharmaceutical Import Trends, 2005 (US$000s)
Leading Suppliers of Pharmaceuticals, 2005 (US$000s)
Leading Suppliers by Category, 2005 (US$000s)
Summary of Pharmaceutical Exports, 2001-2005 (US$ Million)
Raw Materials & Medicaments as Percentage of Pharmaceutical Exports, 2001-2005
Change in Pharmaceutical Exports, 2001-2005 (%)
Leading Destinations of Pharmaceuticals, 2005 (US$000)
Exports of Pharmaceuticals, 2001-2005 (US$000s)
Pharmaceutical Export Trends, 2005 (US$000s)
Pharmaceutical Exports by Leading Destination, 2005 (US$000s)
Balance of Trade in Pharmaceuticals, 2001-2005 (US$000s)
Pharmaceutical Investments by Type, 2007
Key Data, 2007-2012

List of Figures

Pharmaceutical Market Projections, 2007-2012
Radar Graph of the Brazilian Healthcare System, 2007
Pharmaceutical Market, 1997-2006
Pharmacy Sector by Value, 2003-2006
Gross Production, 1996-2004
Number of Producers, 1996-2004
Workforce, 1996-2004
Pharmaceutical Balance of Trade, 2001-2005 (US$ Million)

BRAZIL BACKGROUND DATA

GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
- GDP, 2000-2011
POPULATION
- Population, 2000-2011
- Population by Age Group, July 2000-July 2010 (Million)
- Population by Region, July 2005-July 2006
DEMOGRAPHIC INDICATORS
- Reported Demographic Indicators, 2000-2004
- Estimated Demographic Indicators, 2000-2007
MORTALITY
- Deaths by Selected Cause, 2000-2004
- Deaths by Selected Cause, 2000-2004 (%)
- Change in Deaths by Selected Cause, 2000-2004 (%)
- Detailed Causes of Death, 2004
Infant Mortality
- Infant Mortality by Cause, 1999-2004
MORBIDITY
- Notified Infectious Diseases, 1999-2005
- Notified Infectious Diseases, 1999-2005 (%)
- Change in Notified Infectious Diseases, 1999-2004 (%)
AIDS
- Notified Cases of AIDS by Region, 1980-2005
- Notified Deaths by AIDS, 1980-2004
Cancer
- Estimated Cancer Incidence by Site, 2005
Anaemia

CHARTS

Map of Brazil
Notified Deaths by AIDS, 1980-2004 (000)

BRAZIL HEALTHCARE SYSTEM

ORGANISATION & ADMINISTRATION
- Ministry of Health' s Organisation, 2006
HEALTH EXPENDITURE
- Estimated Health Expenditure, 2003-2012 (US$ Billion)
- Estimated Health Expenditure by Sector, 2000-2003 (%)
Public Health Expenditure
- Public Health Expenditure as % of GDP by Sector, 2000-2003
- Public Health Expenditure by Sector, 2000-2003 (R$ Billion)
- Public Health Expenditure by Sector, 2000-2003 (%)
- Per Capita Public Health Expenditure by Sector, R$ (2000-2003)
- Public Health Expenditure by Sector & Region, 2003 (R$ Billion)
- Public Health Expenditure by Sector & Region, 2003 (%)
HEALTHCARE ESTABLISHMENTS
- Healthcare Establishments, 1985-2005
- Healthcare Establishments by State, 1985-2005
- Healthcare Establishments by Activity & Sector, 1985-2005
- Healthcare Establishments by Activity & Sector, 1985-2005 (%)
- Healthcare Establishments by Sector, 1985-2005
- Healthcare Establishments by State & Sector, 2005
- Healthcare Establishments by Region & Sector, 2005 (%)
- Healthcare Establishments by Region & Activity, 2005
- Healthcare Establishments by Region & Type, 2005
- Public Healthcare Establishments by Region & Type, 2005
- Private Healthcare Establishments by Region & Type, 2005
- Private/SUS Healthcare Establishments by Region & Type, 2005
- Healthcare Establishments by Region & Level of Contracted Services, 2005
HOSPITAL SERVICES
- Healthcare Establishments with Inpatient Facilities by Sector, 1985-2005
- Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
- Healthcare Establishments with Inpatient Facilities by Type & Region, 2005
- Specialist Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
- Healthcare Establishments with Inpatient Facilities, with Specialities, by Sector & Region, 2005
- General Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
SUS Hospitals
- SUS Establishments with Inpatient Facilities by Sector & Provider, 1997-2003
- SUS Establishments with Inpatient Facilities by State & Sector, July 2003
Hospital Beds
- Hospital Beds by Sector, 1985-2005
- Hospital Beds by Sector, 1985-2005 (%)
- Change in Hospital Beds by Sector, 1985-2005 (%)
- Summary of Hospital Beds by Sector & Region, 2005
- Summary of Hospital Beds by Sector & Region, 2005 (%)
- Change in Hospital Beds by Sector & Region, 2002-2005 (%)
- Hospital Beds by Sector & State, 2005
- Summary of SUS Hospital Beds by Sector & Region, 2005
- Summary of SUS Hospital Beds by Sector & Region, 2005 (%)
- Change in SUS Hospital Beds by Sector & Region, 2002-2005 (%)
- Hospital Beds by Sector & State, July 2003
- Hospital Beds by Sector & Speciality, July 2003
- Hospital Beds by Speciality, 1992-2003
Hospital Activity
- Summary of Hospital Admissions by Sector & Region, 2004
- Summary of Hospital Admissions by Sector & Region, 2004 (%)
- Change in Hospital Admissions by Sector & Region, 2001-2004 (%)
- Hospital Admissions by Sector & State, 2004
- SUS Hospital Admissions by Sector, 2000-2005
- SUS Hospital Admissions by Sector, 2000-2005 (%)
- SUS Hospital Admissions by Speciality, 2000-2005
- SUS Hospital Admissions by Speciality, 2000-2005 (%)
- Change in SUS Hospital Admissions by Speciality, 2000-2005 (%)
- SUS Hospital Admissions by Cause Group, 2002-2003
- SUS Hospital Admissions by Cause Group, 2002-2003 (%)
- SUS Hospital Inpatients by Cause, 2003
AMBULATORY CARE
- Healthcare Establishments with Ambulatory Care by Type & Region, 2005
- Healthcare Establishments with Ambulatory Care by Type & Region, 2005 (%)
- Healthcare Establishments with Emergency Services by Region & Specialty, 2005
- Healthcare Establishments with Emergency Services by Region & Specialty, 2005 (%)
- Healthcare Establishments with Emergency Services by Specialty, 2005 (%)
- Healthcare Establishments with Ambulatory & Hospital Care by Sector & Specialty, 2005
- SUS Ambulatory Network by Type, 2001-2003
- SUS Ambulatory Network by Type & Region, July 2003
- SUS Ambulatory Network by Type & Region, July 2003 (%)
- SUS Outpatient Facilities by Type, 2001-2003
- SUS Outpatient Facilities by Provider, 2001-2003
Ambulatory Activity
- SUS Ambulatory Activity by Region, 1997-2005
- Summary of SUS Ambulatory Activity by Type of Procedure, 2000-2004 (Billion)
- Summary of SUS Ambulatory Activity by Type of Procedure, 2000-2004 (%)
- SUS Ambulatory Activity by Provider, 2003 & 2004
- SUS Ambulatory Activity by Type of Procedure, 2000-2004
Second Disease Surveillance & Control Project
Bahia Health System Reform Project
Family Health Extension Programme
MEDICAL EQUIPMENT
- Healthcare Establishments with Diagnostic & Therapy Services by Sector & Specialty, 2005
- Healthcare Establishments with Inpatient Facilities by Sector, Type of Service & Equipment, 2005
- Healthcare Establishments Without Inpatient Facilities by Sector, Type of Service & Equipment, 2005
- Summary of Medical Equipment, 2005
- Summary of Medical Equipment by Type of Provider, 2002
- Summary of Medical Equipment by Type of Provider, 2002 (%)
- Summary of Medical Equipment by Sector, 2005
- Summary of Medical Equipment by Sector & Type of Provider, 2002
- Summary of Medical Equipment by Sector & Type of Provider, 2002 (%)
- Diagnostic Equipment by Type, 2002-2005
- Diagnostic Equipment by Region, 2002-2005
- Diagnostic Equipment by Sector & Type, 2005
- Diagnostic Equipment by Sector & Region, 2005
- Optical Equipment by Type, 2002-2005
- Optical Equipment by Region, 2002-2005
- Optical Equipment by Sector & Type, 2005
- Optical Equipment by Sector & Region, 2005
- Graphical Equipment by Type, 2002-2005
- Graphical Equipment by Region, 2002-2005
- Graphical Equipment by Sector & Region, 2005
- Radiotherapy Equipment, 2002-2005
- Radiotherapy Equipment by Region, 2002-2005
- Radiotherapy Equipment by Sector & Region, 2005
- Life Support Equipment by Type, 2002-2005
- Life Support Equipment by Region, 2002-2005
- Life Support Equipment by Sector & Type, 2005
- Life Support Equipment by Sector & Region, 2005
- Other Medical Equipment by Sector & Type, 2005
- Other Medical Equipment by Sector & Region, 2005
MEDICAL PERSONNEL
- Summary of Health Personnel, 2002-2005
- Summary of Health Professionals by Region, 2005
- Summary of Health Professionals by Region, 2005 (%)
- Change in Health Professionals by Region, 2002-2005 (%)
- Summary of Health Professionals by Sector, 2005
- Summary of Health Professionals by Sector, 2005 (%)
- Change in Health Professionals by Sector, 2002-2005 (%)
- Summary of Health Professionals by Region & Sector, 2005
- Summary of Health Assistants & Technicians by Region, 2005
- Summary of Health Assistants & Technicians by Sector, 2005
- Medical Personnel by Occupation, 2002
- Medical Personnel by Sector & Occupation, 2002
- Change in Medical Personnel by Occupation, 1999 & 2002

CHARTS

Healthcare Establishments, 1985-2005
Healthcare Establishments by Sector, 1985-2005
Healthcare Establishments by Region, 2005 (%)
Healthcare Establishments by Sector, 2005 (%)
Healthcare Establishments by Region & Activity, 2005 (%)
Healthcare Establishments by Sector & Type, 2005
Healthcare Establishments by Region & Type, 2005
Healthcare Establishments by Region & Level of Contracted Services, 2005 (%)
SUS Hospital Admissions by Sector, 1995-2004 (Million)
Healthcare Establishments with Ambulatory Care by Type & Region, 2005
SUS Ambulatory Activity, 1997-2004 (Billion)
Diagnostic & Therapy Services by Sector & Specialty, 2005 (%)
Summary of Medical Equipment, 2005
Summary of Medical Equipment, 2002-2005
Summary of Medical Equipment by Sector, 2005
Doctors, 1992-2005
Summary of Health Professionals by Region, 2005
Health Professionals by Sector, 2005
Summary of Health Professionals by Region & Sector, 2005

BRAZIL ACCESSING THE PHARMACEUTICAL MARKET

INTRODUCTION
REGULATORY ENVIRONMENT
MERCOSUR Regulation
National Regulation
Registration
- Exemptions
Imports
Clinical Trials
Labelling & Packaging
Quality Control
Advertising
Patent Protection & Intellectual Property Rights
Pricing
- Drug Price Adjustments, 2003-2006 (%)
- Implications for the industry
- Excessive taxes on drugs
DISTRIBUTION CHANNELS
Distributors
- Members of ABAFARMA, 2006
- Distribuidora Farmacêutica Panarello
- Profarma
- Profarma' s Operational Indicators, 2003-2006
- Profarma' s Distribution Centres, 2006
- Profarma' s Gross Sales, 2003-2006 (R$ Million)
- Profarma' s Gross Sales, 2003-2006 (US$ Million)
- Profarma' s Leading Pharmaceutical Suppliers, 2005
- Distribuidora Santa Cruz
Pharmacies
- Regulation
- Farmácia Popular do Brasil
Pharmacy & Drugstore Chains
- ABRAFARMA
- Members of ABRAFARMA, 2006
- FEBRAFAR
- Members of FEBRAFAR by Region, 2006
- ASSIFARMA
- ASCOFERJ
TRADE FAIRS
ABRADILAN FARMA
ECONOFARMA
EXPO PHARMA
FARMA RACINE EXPO
FCE PHARMA
FEIRAFARMA
Hospitalar
DOMESTIC PRODUCTION
- Gross Production, 1996-2004
- Gross Production by Leading State, 1996-2004 (R$ Million)
- Workforce, 1996-2004
Trade Associations
- ABIMIP
- Members of ABIMIP, 2006
- ALANAC
- Members of ALANAC, 2006
- ALFOB
- Members of ALFOB, 2006
- FEBRAFARMA
- Members of FEBRAFARMA, 2006
- INTERFARMA
- Members of INTERFARMA, 2006
- Pró-Genéricos
- Members of Pró-Genéricos, 2006
Domestic Producers
- Aché
- Aché' s & Biosintética' s Gross Revenues by Therapeutic Areas, 2005
- Therapeutic Areas Covered by Aché & Biosintética, 2005
- Aché' s Leading Products by Therapeutic Area, 2005
- Biosintética
- Biosintética' s Sales, 2001-2004
- Biosintética' s Pharmaceutical Sales by Therapeutic Areas, 2004
- Barrenne Industria Farmacêutica
- Barrenne' s Leading Products, 2005
- Biolab
- Cimed
- Cristália' s Business Units, 2006
- Cristália' s International Representatives, 2006
- EMS-SIGMA PHARMA
- Eurofarma
- Farmasa
- JP Indústria Farmacêutica
- Libbs Farmacêutica
- Libbs' Pharmaceutical Sales, 2000-2006
- Medley
- Medley' s International Agreements, 1992-2005
- Nortec Química
- Teuto
- Vitapan
Multinational Activity
- Abbott
- Allergan
- Altana
- AstraZeneca
- Bayer-Schering
  - Bayer
  - Schering
- Boehringer Ingelheim
- Boehringer Ingelheim' s Financial Data, 2002-2005
- BI' s Leading Product Launches, 2000-2005
- Bristol-Myers Squibb
- Eli Lilly
- Farmalab Chiesi
- GlaxoSmithKline
- Merck
- Merck Sharp & Dohme
- Novartis
- Novo Nordisk
- Pfizer
- Roche
- Sanofi-Aventis
- Sanofi-Aventis' s Launched Pharmaceuticals, 2005
- Schering Plough
- Wyeth
Research & Development
- 2004-2007 National Industrial Policy
- Demands by Domestic Pharmaceutical Producers to the Ministry of Science & Technology, 2005
- Profarma & Progeren
- Profarma' s Objectives, 2005
DIRECTORY
Government Organisations
Trade Associations

CHARTS

Gross Production, 1996-2004
Change in Gross Production, 1997-2004 (%)
Production by Leading State, 2004 (%)
Number of Producers, 1996-2004
Workforce by Leading State, 2004 (%)
Workforce, 1996-2004
Aché' s & Biosintética' s Gross Turnover & Number of Products, 2005
Aché' s Gross Revenues, 2001-2005 (R$ Million)
Aché' s Gross Revenues, 2001-2005 (US$ Million)
Biosintética' s Sales, 2001-2004
Libbs' Pharmaceutical Sales, 2000-2006
Pfizer' s Projected Sales, 2005-2007

China Pharmaceutical Market Intelligence Report

EXECUTIVE SUMMARY
PHARMACEUTICAL MARKET
Current Size
Projections
Outlook
Market Structure
- Generics
- OTC Market
- Domestic Production
  - 11th Five Year Plan Targets
  - HIV/AIDS drugs
- Imports
- Exports
- Research & Development
  - SFDA initiatives
Market Developments
- SFDA shuts down 300 drug & medical device manufacturers
- Stricter GMP Inspection Guidelines from 2008
- GSK to invest US$100 million in neuroscience research centre
- Sanofi-Aventis invests over US$100 million in vaccine plant
- Drug centre in Shanghai to tackle cancer and diabetes
- MoH improves basic rural medical care coverage
  - Central Government Adopts Five-Year Health Plan
- Former SFDA Chief Executed for Corruption
- Medical Insurance to Cover all Urban Citizens
  - China Sets up Medical Insurance Research Institute
- China May End Tax Benefits for Foreign Companies
- China Strives to Wipe Out Bird Flu by 2015
- China Imposes Stricter Quality Checks on 170,000 Medicines
- China Considers Sending More Doctors to Rural Areas
- Almost 500,000 Chinese Die of Hepatitis B Annually
- Central Government Adopts Five-Year Health Plan
- Beijing to Build Network for Infectious Diseases Before 2008 Olympics
- China Bans Exports of Human Organs
- X-ray Fees Capped at Beijing Hospitals
- New Rule on Prescription of Drugs Effective May 2007
- Medical Ads Require Approval of Provincial Health Departments
- China Seeks Companies to Develop or Produce its New Bird Flu Vaccine
- Traditional Chinese Medicine
  - Manufacturers
  - China Conducts Research on Toxicity and Side Effects of TCM
- HIV/AIDS
- World Bank Projects
  - Tuberculosis Control Project
  - Basic Health Services Project
KEY NATIONAL DATA PROJECTIONS
This page left intentionally blank
Methodology and Sources

List of Tables

Summary of the Chinese Pharmaceutical Market in 2007
Projected Pharmaceutical Market, 2007-2012
SWOT Analysis of the Chinese Pharmaceutical Market
Espicom Analysis of China' s Health Sector
Chinese Medical/Pharmaceutical Production, 2002 and 2004
Summary Pharmaceutical Imports, 2001-2005 (US$000s)
Leading Suppliers of Raw Materials, 2005 (US$000s)
Leading Suppliers of Medicaments, 2005 (US$000s)
Imports of Pharmaceuticals, 2001-2005 (US$000s)
Import Trends, 2005 (US$000s)
Leading Suppliers, 2005 (U$000s)
Leading Suppliers by Category, 2005 (US$000s)
Summary Pharmaceutical Exports, 2001-2005 (US$000s)
Exports of Pharmaceuticals 2001-2005
Leading Destinations, 2005 (U$000s)
Pharmaceutical Balance of Trade, 2001-2005
Key Data, 2007-2012

List of Figures

Pharmaceutical Imports, Exports & Balance of Trade, 2001-2005 (US$000s)
Total Market Projections, 2007-2012 (US$ billions)
Per Capita Market Projections, 2007-2012 (US$)
Radar Graph of the Chinese Healthcare System
Imports of Raw Materials/Retail Medicaments, 1999-2005 (US$000s)
Leading Suppliers, 2005 (%)
Exports by Category, 2005 (%)
Leading Destinations, 2005 (%)

CHINA BACKGROUND DATA

Geographic
Political
Economic
- Economic Projections 2007-2012
Population
- Population Estimates, 1991-2005
- Population by Province, December 2005
Population Growth
Demographic Indicators
- Principal Demographic Indicators, 2000-2005
- Demographic Indicators by Province, 2005
Mortality
- Major Causes of Death, 1999
- Major Causes of Death in Urban Areas, 1999-2005
- Major Causes of Death in Rural Areas, 1999-2005
Morbidity
- Reported Infectious Diseases, 1999-2005 (Rate per 100,000 population)
  - HIV/AIDS
  - Tuberculosis
  - Tobacco

CHINA HEALTHCARE SYSTEM

ORGANISATION & ADMINISTRATION
Ministry of Health
- Hospitals
- Rural Healthcare
- Health Insurance
- New Co-operative Medical Scheme (formerly Rural Co-operative Medical Scheme)
NCMS Funding and Expenditure 2005
- Commercial Medical Insurance
- Red Cross Society of China
HEALTH EXPENDITURE
- Total Health Expenditure, 1997-2004 (Yuan billions)
HOSPITAL SERVICES
Healthcare Facilities
- Healthcare Institutions by Type, 2000-2005
- Healthcare Institutions by Type, 2002
- Healthcare Institutions by Type and Province, 2005
  - Joint Venture Hospitals
Hospital Beds
- Healthcare Beds, 1995-2005 (000s)
- Number of Beds in Healthcare Institutions by Type, 2001-2005
- Beds by Region, 2005
  - Private Hospitals
Hospital Activity
- Admissions, 2000-2005 (millions)
- Hospital Admissions by Type (10,000s), 2005
- Hospital Bed Utilisation Statistics, 1993-2005
AMBULATORY CARE
- Outpatient Facilities, 2001-2005
  - Hospital Outpatient Activity
- Hospital Outpatient Visits, 1999-2005 (millions)
- Outpatient Visits by Establishment, 2005
- Outpatient Visits by Type (millions), 2005
MEDICAL PERSONNEL
- Medical Personnel (000s), 2001-2005
- Medical Personnel by Province, 2005

CHINA ACCESSING THE PHARMACEUTICAL MARKET

INTRODUCTION
REGULATORY ENVIRONMENT
Pharmaceutical Registration
- Revised Provisions for Drug Registration 2007
State Food and Drug Administration (SFDA)
- Department of Drug Registration
- Department of Drug Safety & Inspection
- Department of Drug Market Compliance
- Drug Classification
- Biotech regulation
New Regulatory Legislation
- 2001 DAL Amendments
- The Drug Import Regulation
GMP Regulations
Pharmaceutical Registration/Drug Approval Process
- Clinical trials
- Quality test
- Certification
Packaging Regulations
Post-market Surveillance
- Licences of 160 drug firms revoked in 2006
Pharmaceutical Advertising
Patent Protection & Intellectual Property Rights
- Administrative Protection
Pharmaceutical Pricing and Reimbursement
- Pricing
- Pricing Sector Developments
- Provincial governments
- Reimbursement Lists
DISTRIBUTION CHANNELS
- Distribution System Reform
- Internet Pharmaceutical Distribution
- Pharmaceutical retail
Distributors
- Chindex
- Hainan Kangtong Pharmaceutical Co Ltd.
- Hunan Provincial Medicines & Health Products Import & Export Corp.
- Shandong Medicines & Health Products Import & Export Corp.
- Sincer Pharmchem Ltd
- Sinochem Jiangsu Suzhou Import Export Corp.
- Tianjin Medicines & Health Products Import & Export Corp.
DOMESTIC PRODUCTION
- Chinese Medical/Pharmaceutical Production, 2002 and 2004
  - 11th Five Year Plan Targets
  - HIV/AIDS drugs
Domestic Producers
- Anhui Anke Biotech
- Beijing Four Ring Pharmaceutical Factory
- Changzhou Siyao Pharmaceuticals Co. Ltd
- China Pharmaceutical Enterprise
- Dragon Pharmaceuticals
- Dragon Pharmaceuticals Revenues by Segment, 2006 (US$ millions)
- Fuzhou Antibiotic Group Corp
- Haizhou Pharmaceutical Co. Ltd
- Harbin Pharmaceutical Group Co. Ltd
- Heshuo Ephedrine Factory
- Huazhong Pharmaceutical Co. Ltd
- Jiangsu Jiangan Pharmaceutical Corp Ltd
- Jiuyuan
- Livzon (Group) Libao Biochemical & Pharmaceutical Co Ltd
- Ningbo Jierfu Pharmaceutical Co Ltd
- North China Pharmaceutical Huasheng Co. Ltd
- Shenyang Sunshine Pharmaceutical Co Ltd
- Shenzhen Kexing Biotech
- Shenzhen Zhijun Pharmaceutical Company
- Shenzhen Taitai Pharmaceutical Industry (Taitai)
- Sinovac Biotech Ltd.
- Wenzhou Pharmaceutical Factory
- Xiamen No.2 Pharmaceutical Factory
- Xi' an Pharmaceutical Factory
- Xinhua Pharma
- Yiyuan Pharmaceutical Co Ltd
- Zhejiang Jinhua Lixin Fine Chemicals Co Ltd
Multinational Producers
- Allergan
- Antibioticos
- Astellas Pharma
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson
- Laboratories Servier
- Merck KGaA
- Merck Sharp & Dohme
- Novartis
- Novo Nordisk
- Pfizer
- Ranbaxy
- Rexim SA (Degussa)
- Roche
- Sanofi-Synthèlabo
- Schering-Plough
- Takeda
- Tanabe
- Watson
- Wyeth
Research & Development
- SFDA initiatives
- Zhangjiang Hi-Tech Park
- Beijing Union Pharmaceutical Factory
DIRECTORY

India Pharmaceutical Market Intelligence Report

EXECUTIVE SUMMARY
PHARMACEUTICAL MARKET
Current Size
Projections
Outlook
Market Structure
- Domestic production
- Multinationals
- Trade Associations
- Pharmaceutical Imports
- Raw Material Imports
- Finished Medicament Imports
- Exports
- Research & Development
- Traditional Indian Medicines
Market Developments
- Pfizer becomes first MNC to get Indian patent for anti-AIDS drug
- Indian government cracks down on overcharging
- Novartis' s challenge to Indian patent law dismissed by High Court
- Satwant Reddy Committee Report on Data Protection, May 2007
- Mashelkar Committee Report, December 2006
- India may have overestimated HIV/AIDS burden
- India ranks top in contract research
- Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
- The Patents (Amendment) Rules 2006
- Government Task Force on Drug Pricing
- National Pharmaceuticals Policy 2006
KEY NATIONAL DATA PROJECTIONS
Methodology and Sources
Trade Code Classifications

List of Tables

Summary of the Indian Pharmaceutical Market in 2007
Projected Pharmaceutical Market, 2007-2012
SWOT Analysis of the Indian Pharmaceutical Market
Analysis of India' s Health Sector
Global Sales by Leading Domestic Companies, 12 months ended 31st March 2007
Pharmaceutical Import Summary, 2001-2005 (US$000s)
Leading Suppliers, 2005 (US$000s)
Leading Suppliers of Raw Materials, 2005
Leading Suppliers of Finished Medicaments, 2005
Imports of Pharmaceuticals, 2001-2005 (US$000s)
Pharmaceutical Import Trends
Leading Suppliers, 2005 (US$000s)
Leading Suppliers by Category, 2005 (US$000s)
Pharmaceutical Export Summary, 2001-2005 (US$000s)
Exports of Pharmaceuticals, 2001-2005 (US$000s)
Pharmaceutical Export Trends
Pharmaceutical Exports by Destination, 2005 (US$000s)
Balance of Trade in Pharmaceuticals, 2001-2005 (US$000s)
Key Data Projections, 2007-2012

INDIA BACKGROUND DATA

GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
POPULATION
- Population by States and Territories, 2001-2007
DEMOGRAPHIC INDICATORS
- Demographic Indicators, 1996-2006
- Demographic Indicators by State, 2006
MORTALITY
- Medically Certified Deaths by Cause, 2000
- Major Causes of Death, Rural India 1993-1998
- Deaths from Non-Communicable Diseases, 1998
MORBIDITY
National Rural Health Mission
Child Survival and Safe Motherhood
- Reproductive and Child Health Programme
- Universal Immunisation Programme
  - Reported Incidence of Vaccine Preventable Diseases, 1985-2006
- Reducing Fertility
  - Family Planning
  - All India Hospitals Post-Partum Programme
National Health Programmes for Disease Control/Eradication
- National Vector Borne Disease Control Programme
  - Malaria
    - Reported Malaria Incidence & Deaths, 1996-2006
  - Filariasis
  - Kala-azar
    - Reported Kala-azar Cases & Deaths, 1996-2006
  - Japanese Encephalitis
    - Suspected Japanese Encephalitis Cases & Deaths, 2000-2006
- National Programme for the Control of Blindness
- National Leprosy Eradication Programme
- National Tuberculosis Control Programme
- HIV/AIDS
  - National AIDS Control Programme
- Cancer
  - Leading Cancer Sites in Males (HBCR), 2001-2003
  - Leading Cancer Sites in Females (HBCR), 2001-2003

CHARTS

Map of India
Population by Age Group, 2006 (%)
Medically Certified Deaths by Cause, 2000

INDIA HEALTHCARE SYSTEM

ORGANISATION & ADMINISTRATION
Department of Health and Family Welfare
The Department of AYUSH
Health Insurance
- Apollo Family Health Plan
HEALTH EXPENDITURE
- Health Expenditure by Source of Funds, 2001/02
- Department of Health & Family Welfare: Health Sector Expenditure by Scheme, 2005/06
HOSPITAL SERVICES
Hospital Resources
- Hospitals & Beds by State & Sector, 2002
- Government Hospitals/CHCs and Beds by State, 2007
- Hospitals, Dispensaries & Beds, 1991-1998
- Beds in Selected Hospitals, 2006
- All India Institute of Medical Sciences (AIIMS)
  - AIIMS Hospital Beds, 2005/06
  - AIIMS Hospital Activity, 2005/06
  - AIIMS Inpatients by Specialty, 2005/06
- Safdarjung Hospital, New Delhi
  - Safdarjung Hospital Beds by Specialty, 2003
- Dr. Ram Manohar Lohia Hospital, New Delhi
  - Dr. Ram Manohar Lohia Hospital Beds by Specialty, 2000/01
- JIPMER Hospital, Pondicherry
  - JIPMER Hospital Beds by Specialty, 2000
- PGIMER Nehru Hospital, Chandigarh
  - PGIMER Nehru Hospital Beds by Specialty, 2004/05
- Lady Hardinge Medical College Associated Hospitals, New Delhi
Private Hospitals and Clinics
- Apollo Hospitals Group
- Fortis Healthcare
- Max Healthcare
- Other Commercial Providers
AMBULATORY CARE
- Sub-centres and Primary Health Centres, 2004-2006
- CGHS Out-patient Facilities, 31st March 2006
First Aid and Disaster Relief
- St. John Ambulance
- Indian Red Cross Society
Healthcare for the Underprivileged, Scheduled Castes and Scheduled Tribes
- Healthcare Infrastructure in Tribal/Scheduled Caste Areas, 1995-2005
Medical Care for Remote & Marginalised Tribal & Nomadic Communities
MEDICAL PERSONNEL
- Doctors Registered with State Medical Councils, 1995-2005
- Registered Dental Surgeons, 1995-2005
- Registered Nursing Personnel, 1995-2005
- Healthcare Personnel in Rural Areas, 1998-2006

CHARTS

Health Expenditure by Source, 2001/02 (%)

INDIA ACCESSING THE PHARMACEUTICAL MARKET

INTRODUCTION
REGULATORY ENVIRONMENT
National Pharmaceuticals Policy 2006
Pharmaceutical Registration
Advertising
Patent Protection & Intellectual Property Rights
- Background to Pharmaceutical Patents
- Mashelkar Committee Report, December 2006
- The Patents (Amendments) Bill, 2005
  - Compulsory Licensing
  - Pre- & Post-Grant Opposition
  - Mailbox Applications
  - Other Issues
- The Patents (Amendment) Rules 2006
- Previous Patents Act Amendments and Exclusive Marketing Rights
  - Glivec/Gleevec Patent Setback for Novartis
Pricing
- Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
- Drug Price Control Review Committee
DISTRIBUTION CHANNELS
- Medical Stores Organisation
TRADE FAIRS
- Biotech India 2007
- India Chem 2008
- Pharma Bio World Expo 2009
DOMESTIC PRODUCTION
- Global Sales by Leading Domestic Companies, 12 months ended 31st March 2007
BCG Vaccine Laboratory, Chennai
Trade Associations
Domestic Producers
- Alembic Ltd
  - Alembic: Manufacturing Facilities
  - Alembic Financial Results, 2003-2007
- Aurobindo Pharma
  - Aurobindo Pharma: Manufacturing Facilities
  - Aurobindo Pharma: ANDA Approvals, 2004-2008
  - Cephazone Pharma: FDA ANDA Approval, 2007
  - Aurobindo Pharma: Financial Results, 2003-2007
- Biocon
  - Biocon Financial Results, 2003-2007
- Blue Cross Laboratories Ltd
- Cipla Ltd
  - Cipla: Manufacturing Facilities
  - Cipla: FDA ANDA Approvals, 2007
  - Cipla: Tentative FDA ANDA Approvals
  - Cipla: Tentative FDA NDA Approvals
  - Cipla: Financial Results, 2003-2007
- Dr. Reddy' s Laboratories Ltd
  - Dr. Reddy' s: Manufacturing Facilities
  - Dr. Reddy' s: FDA ANDA Approvals, 2002-2008
  - Dr. Reddy' s: Financial Summary, 2003-2007
- Glenmark Pharmaceuticals
  - Glenmark: Manufacturing Facilities
  - Glenmark: FDA ANDA Approvals, 2006-2007
  - Glenmark: Financial Results, 2003-2007
- Lupin Limited
  - Lupin: Manufacturing Facilities
  - Lupin: FDA ANDA Approvals 2003-2008
  - Lupin: Tentative FDA Approvals
  - Lupin: Financial Results, 2003-2007
- Matrix Laboratories
  - Matrix: Manufacturing Facilities
  - Matrix FDA ANDA Approval, 2008
  - Matrix: Tentative FDA ANDA Approvals
  - Matrix: Financial Results, 2003-2007
- Natco Pharma
  - Natco Pharma Financial Results, 2003-2007
- Nicholas Piramal India Ltd
  - NPIL: Manufacturing Facilities
  - NPIL: Financial Results, 2003-2007
- Orchid Chemicals & Pharmaceuticals Ltd
  - Orchid: Manufacturing Facilities
  - Orchid' s Top-10 Brands
  - Orchid: FDA ANDA Approvals, 2005-2008
  - Orchid: Financial Results, 2003-2007
- Ranbaxy Laboratories Ltd
  - Ranbaxy: Manufacturing Facilities
  - Ranbaxy Laboratories: FDA ANDA Approvals, 2002-2007
  - Ohm Laboratories: FDA ANDA Approvals, 2006-2007
  - Ranbaxy Financial Results, 2003-2007
- Sun Pharma
  - Sun Pharma: Manufacturing Facilities
  - Sun Pharma: FDA ANDA Approvals, 2006-2007
  - Caraco Pharmaceutical: ANDA Approvals, 2002-2008
  - Sun Pharma: Financial Results, 2003-2007
- Wockhardt Ltd
  - Wockhardt Manufacturing Facilities
  - Wockhardt: FDA ANDA Approvals, 2003-2008
  - Wockhardt: Financial Results, 2003-2006
- Zydus Cadila
  - Zydus Cadila: Manufacturing Facilities
  - Zydus: ANDA Approvals, 2005-2008
  - Zydus Cadila: Consolidated Results, 2006-2007
  - Cadila Healthcare: Financial Results, 2003-2007
  - Zydus Cadila: Domestic Formulations Sales by Therapy Area, 2006
- Multinational Activity
- Actavis
- GlaxoSmithKline
- Pfizer India
- sanofi-aventis
Research & Development
- New Millennium Indian Technology Leadership Initiative
- Indian Council of Medical Research
- Central Research Institute, Kasauli
- Central Drug Research Institute, Lucknow
- Central Council for Research in Unani Medicine
- Central Council for Research in Ayurveda and Siddha
- Central Council for Research in Homeopathy
Traditional Indian Medicines
- Components
- Ayurvedic Supply
DIRECTORY
Government Organisations
Trade Associations

CHARTS

Cipla: Exports by Region, 2007 (%)
Dr. Reddy' s: Sales by Region, 2007 (%)
Glenmark: Formulations Sales by Region, 2007 (%)
Matrix: Sales by Region, 2006 (%)
Orchid: API Sales by Region, 2007 (%)
Orchid: Formulations Sales by Region, 2007 (%)
Wockhardt: Sales by Region, 2006 (%)
Zydus Cadila: Sales by Region, 2007 (%)

Russia Pharmaceutical Market Intelligence Report

EXECUTIVE SUMMARY
PHARMACEUTICAL MARKET
Current Size
Projections
Outlook
Market Structure
- Pharmacy Market
- Hospital Market
- Generics
- OTC Market
- Domestic Production
- Multinationals
- Imports
- Exports
- Research & Development
Market Developments
- Obligatory Medical Insurance (OMI)
- Drug Reimbursement System
  - DLO Market in Q1-Q3 2006
- Clinical Trials
- Corruption within the Health Insurance System
- Medicines Budget Increased
- 2006-2008 Budget
- Counterfeit Drugs
- HIV/AIDS Report Indicates Worsening Epidemic
- Talks with Belarus to Strengthen Drug Trade
- Guaranteed Medical Services
- World Bank Projects
  - Health Reform Implementation Project
  - TB & AIDS Control Project
KEY NATIONAL DATA PROJECTIONS
Methodology and Sources

List of Tables

Summary of the Russian Pharmaceutical Market in 2007
Projected Pharmaceutical Market, 2007-2012
SWOT Analysis of the Russian Pharmaceutical Market
Espicom Analysis of the Russian Healthcare Sector
Top Ten ATC Groups by Pharmacy Sales Value, 2003-2005 (%)
Top Ten ATC Groups by Hospital Purchases, 2003-2005 (%)
Generic and Original Drugs by Market Share, 2004-2007 (%)
Generic and Original Drugs in the DLO Market by Share, 2005-2007 (%)
Top Ten Generic Drugs in the Retail Sector, Q1-Q2 2007
Top Ten Generic Companies, Q1-Q2 2007
Top Ten Manufacturers, Trade Names and ATG Groups in the OTC Market, 2005
Top Ten Domestic Producers, 2006 (US$ millions)
Russian Pharmaceutical Output, 2000-2003 (US$ millions)
Top Pharmaceutical Companies by Sales, 2004-2006 (%)
Pharmaceutical Imports, 2001-2005 (US$000s)
Leading Suppliers of Raw Materials, 2005 (US$000s)
Leading Suppliers of Medicaments, 2005 (US$000s)
Pharmaceutical Imports, 2001-2005 (US$000s)
Pharmaceutical Import Trends, 2005 (US$000s)
Leading Suppliers, 2005 (US$000s)
Leading Suppliers by Category, 2005 (US$000s)
Pharmaceutical Exports, 2001-2005 (US$000s)
Exports of Pharmaceuticals, 2001-2005 (US$000s)
Exports by Leading Destination, 2005 (US$000s)
Pharmaceutical Balance of Trade, 2001-2005 (US$000s)
Top 10 ATCs Purchased under the Federal Budget, 2006
Top 10 Manufacturers by DLO Value, 2005-2006
Top 10 Products by DLO Value, 2005-2006 (%)
Top 10 ATC Groups by DLO Value, 2005-2006 (%)
Key Data Projections, 2007-2012

List of Figures

Pharmaceutical Imports, Exports & Balance of Trade, 1998-2005 (US$000s)
Percentage Change in Imports and Exports, 1999-2005
Market Projections, 2007-2012
Radar Graph of the Russian Healthcare System
Imports by Category, 2005 (%)
Leading Suppliers, 2005 (%)
Exports by Category, 2005 (%)

RUSSIA BACKGROUND DATA

GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
- Economic Indicators, 1995-2012
POPULATION
- Population by Age and Sex, 2006
- Population by District, 2001
DEMOGRAPHIC INDICATORS
- Principal Demographic Indicators, 1995-2005
MORTALITY
- Deaths by Cause, 2004-2005
  - Infant Mortality
- Infant Mortality by Cause, 2004-2005
MORBIDITY
- Incidence of Morbidity by Diagnosis, 2005 (000)
- Incidence of Morbidity by Diagnosis, 2000-2005 (000)
Infectious Diseases
- Infectious Diseases, 2000-2001
  - Tuberculosis
  - HIV/AIDS
- Reported Cases of HIV, 2000-2005

CHARTS

Map of Russia
Population, 1989-2006 (millions)
Population by Age Group, 2006 (%)
Leading Causes of Death, 2005 (%)

RUSSIA HEALTHCARE SYSTEM

ORGANISATION & ADMINISTRATION
HEALTH EXPENDITURE
- Hospital funding change proposed
HOSPITAL SERVICES
- Public Hospitals, 1996-2005
- Hospital Beds, 1997-2005
MoH Facilities
- MOH Inpatient Facilities, 2002-2005
- Public Hospital Beds by Specialty, 2003-2005
Hospital Activity
- Hospital Discharges by Group of Diseases, 2002-2005
- Hospital Activity, 1998-2005
- Bed Occupancy (Days) By Type of Hospital, 1999-2001
  - Surgical procedures
- Surgical Operations In Hospitals, 2003-2005
AMBULATORY CARE
- Outpatient Care Facilities, 1997-2005
MoH Facilities
- Outpatient Facilities and Polyclinics, 2002-2005
- Surgical Operations in Polyclinics & Outpatient Units, 2000-2005
- Surgical Operations in Polyclinics, 2000-2001
Day Surgery
- Day Surgeries, 2003-2005
- Day Surgery Discharges by Group of Diseases, 2003-2005
MEDICAL PERSONNEL
- MoH Medical Personnel, 1998-2005
- MoH Doctors by Type, 2002-2004
- MoH Doctors by Leading Specialty, 2002-2005 (000s)

RUSSIA ACCESSING THE PHARMACEUTICAL MARKET

INTRODUCTION
REGULATORY ENVIRONMENT
- VAT on Pharmaceuticals
Pharmaceutical Registration
Import Regulations
Advertising
Patent Protection & Intellectual Property Rights
- Counterfeit Medicines
Pricing and Reimbursement
- Drug Pricing
- Reimbursement
DISTRIBUTION CHANNELS
Distributors
- Protek
- Shreya Corporation
- SIA International
TRADE FAIRS
- Hospital
- Pharmtech 2006
DOMESTIC PRODUCTION
- Top Ten Domestic Producers, 2006 (US$ millions)
- Russian Pharmaceutical Output, 2000-2003 (US$ millions)
Trade Associations
- AIPM
Domestic Producers
- Akrikhin
- Bryntsalov A
- JSC Farmacon
- KRKA
- Nizhpharm
Nizhpharm Sales, 1999-2003
- Otechestvennye Lekarstva (Erka Farm)
- Pharmstandard
- Veropharm
- Yugrafarm
Multinationals
- Top Pharmaceutical Companies by Sales, 2004-2006 (%)
Research & Development
DIRECTORY
Government Organisations
Regional Health Authorities
Trade Associations

医薬品のブラジル・ロシア・インド・中国市場

The Market for Pharmaceuticals in Brazil, Russia, India & China 2008

Abstract

Putting things in perspective

Opportunities do exist

A long haul

Current and accurate decision support information is vital

Table of Contents

Brazil Pharmaceutical Market Intelligence Report

List of Tables

List of Figures

BRAZIL BACKGROUND DATA

CHARTS

BRAZIL HEALTHCARE SYSTEM

CHARTS

BRAZIL ACCESSING THE PHARMACEUTICAL MARKET

CHARTS

China Pharmaceutical Market Intelligence Report

List of Tables

List of Figures

CHINA BACKGROUND DATA

CHINA HEALTHCARE SYSTEM

CHINA ACCESSING THE PHARMACEUTICAL MARKET

India Pharmaceutical Market Intelligence Report

List of Tables

INDIA BACKGROUND DATA

CHARTS

INDIA HEALTHCARE SYSTEM

CHARTS

INDIA ACCESSING THE PHARMACEUTICAL MARKET

CHARTS

Russia Pharmaceutical Market Intelligence Report

List of Tables

List of Figures

RUSSIA BACKGROUND DATA

CHARTS

RUSSIA HEALTHCARE SYSTEM

RUSSIA ACCESSING THE PHARMACEUTICAL MARKET